Grimes & Company’s Axon Enterprise AXON Stock Holding History

Grimes & Company’s Portfolio AXON Stock Details AXON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,060	Closed	-$761K	–	463
2025 Q3	$761K	Buy	+1,060	New	+$804K	0.02%	256

Other funds holding AXON

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Grimes & Company's AXON Position: Q4 2025 in Review

Grimes & Company sold out of Axon Enterprise (AXON) in Q4 2025, closing a stake of 1,060 shares — an estimated $761K sold.

Grimes & Company first reported a position in AXON in Q3 2025 and held it in 1 quarter. The position peaked at $761K in Q3 2025. 1,137 funds tracked by Wall St. Rank hold AXON as of Q4 2025.

Grimes & Company reported no remaining Axon Enterprise position as of Q4 2025 after selling out during the quarter.
Grimes & Company sold 1,060 Axon Enterprise shares in Q4 2025, an estimated $761K.
Grimes & Company first reported a position in Axon Enterprise in Q3 2025 and held it in 1 quarter.
Grimes & Company's Axon Enterprise position peaked at $761K in Q3 2025.
1,137 funds tracked by Wall St. Rank held Axon Enterprise as of Q4 2025.

Based on Grimes & Company's 13F filing for Q4 2025, filed 3 Feb 2026.